Another ginsenoside, Rh2, has also been shown to alter the TME by inducing conversion of TAMs from an M2 to an M1 phenotype that, in turn, prevented tumor cell migration and secretion of tumor angiogenetic factors (Li H. et al., 2018). This evidence concerns the gene RHAG and neoplasm.